Semiconductor Chip and Time Domain Sequencing™ Technology Will Advance Drug Discovery and Diagnostics, Enabling People to Live Healthier and Longer Lives Next-generation single-molecule protein ...

With a dizzying range of strategies available, laboratories must weigh up their options to find the best fit for their projects There’s an old saying in the field of technology: “Nobody ever got fired ...

In a development that could accelerate the discovery of new diagnostics and treatments, researchers have developed a versatile and low-cost technology for targeted sequencing of full-length RNA ...

Quantum-Si's technology has potential in drug discovery and biomarker test development. The company's Platinum sequencing platform is set to launch. Platinum sequencing platform expected to drive ...

According to Jonathan M. Rothberg, Ph.D., CEO, founder, and chairman of Ion Torrent, his company’s semiconductor sequencing technology represents a quantum advancement in DNA sequencing. Ion Torrent™ ...

PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...

The most exclusive club in omics has admitted only genomics and transcriptomics, the beneficiaries of single-molecule sequencing technologies that are so powerful they enable highly refined ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified new sites in the placenta where genomic imprinting occurs. This could find previously ...

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that its wholly owned subsidiary ...